Maragin Health Foundation is a 501(c)(3) non-profit biomedical research organization headquartered in Irving, Texas. Operating like an academic lab, Maragin funds early-stage scientific projects that are too preliminary for commercial investment but hold strong potential for future impact. By validating key findings and reducing development risk, Maragin bridges academia and industry, partnering with universities, sharing revenues with collaborators, and creating an evergreen funding model that continually fuels new biomedical innovation.
Maragin Health works across two centers: The Center for Evaluation & Translational Innovation (CETI) and the Center for Human Aging and Performance (CHAP).
The Center for Evaluation & Translational Innovation at Maragin Health Foundation bridges the gap between scientific discovery and real-world patient impact. While groundbreaking research is generated every day in universities, research institutes, and early-stage companies, many promising innovations never reach the people who could benefit from them. CETI helps overcome this challenge by providing scientific, technical, and strategic support across the development pathway - from poof-of-concept and technology validation to product development, manufacturing, and clinical translation. By combining expertise in biomedical research, drug development, artificial intelligence, and healthcare innovation, CETI accelerates the transformation of breakthrough discoveries into practical solutions that improve public health and benefit society.
CHAP is a new initiative focused on measuring, understanding, and improving functional aging. Aging is not defined by time alone. Two people may both be 80 years old, yet differ vastly in mobility, cognition, recovery, and quality of life. CHAP was created to answer one central question: How well is a person aging?
The Maragin Health Foundation is based at 1551 Corporate Dr in Irving, Texas and shares a facility with the MEDNA Protein Innovation Center.